Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-12 Option Award | 2024-06-14 5:35 pm | N/A 2034-06-12 | Blueprint Medicines Corp | BPMC | Seely Lynn Director | 6,812 | $0 | 17,824 (Direct) | View |
2024-02-09 Option Award | 2024-02-13 8:17 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 200,000 | $0 | 200,000 (Direct) | View |
2023-11-16 Disposition | 2023-11-20 8:53 pm | N/A 2032-12-14 | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 7,500,000 | $0 | 7,500,000 (Direct) | View |
2023-11-16 Option Award | 2023-11-20 8:53 pm | N/A 2032-12-14 | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 7,500,000 | $0 | 7,500,000 (Direct) | View |
2023-06-21 Option Award | 2023-06-23 7:06 pm | N/A 2033-06-21 | Blueprint Medicines Corp | BPMC | Seely Lynn Director | 7,900 | $0 | 16,312 (Direct) | View |
2022-12-15 Option Award | 2022-12-19 4:20 pm | N/A 2032-12-14 | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 7,500,000 | $0 | 7,500,000 (Direct) | View |
2022-06-21 Option Award | 2022-06-30 9:52 pm | N/A 2032-06-21 | Blueprint Medicines Corp | BPMC | Seely Lynn Director | 7,900 | $0 | 13,712 (Direct) | View |
2022-06-08 Option Award | 2022-06-10 4:16 pm | N/A 2032-06-07 | Lyell Immunopharma Inc. | LYEL | Seely Lynn Director | 65,000 | $0 | 65,000 (Direct) | View |
Ownership | 2021-06-16 7:23 pm | N/A 2031-05-19 | Lyell Immunopharma Inc. | LYEL | Seely Lynn Director | 0 | $0 | 400,000 (Direct) | View |
2021-06-02 Option Award | 2021-06-04 4:16 pm | N/A 2031-06-02 | Blueprint Medicines Corp | BPMC | Seely Lynn Director | 6,750 | $0 | 10,312 (Direct) | View |
2020-06-24 Option Award | 2020-06-26 4:09 pm | N/A 2030-06-24 | Blueprint Medicines Corp | BPMC | Seely Lynn Director | 6,750 | $0 | 8,062 (Direct) | View |
2020-06-19 Exercise | 2020-06-23 4:14 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Seely Lynn Director | 1,312 | $0 | 1,312 (Direct) | View |
2020-04-03 Option Award | 2020-04-07 5:16 pm | N/A 2030-04-02 | Myovant Sciences Ltd. | MYOV | Seely Lynn Principal Executive Officer | 500,352 | $0 | 2,192,685 (Direct) | View |